Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jukka Kero

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Genesis (New York, N.Y. : 2000)|January 8, 2014
A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activityHenriette Undeutsch, Christoffer Löf, Stefan Offermanns, et al.
Endocrinology|September 20, 2002
Transgenic mice harboring murine luteinizing hormone receptor promoter/beta-galactosidase fusion genes: different structural and hormonal requirements of expression in the testis, ovary, and adrenal glandTuula Hämäläinen, Jukka Kero, Matti Poutanen, et al.
The Journal of Clinical Investigation|February 15, 2011
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cellsMartina Lukasova, Camille Malaval, Andreas Gille, et al.
Molecular Pharmacology|August 16, 2005
Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G)Sorin Tunaru, Jens Lättig, Jukka Kero, et al.
Molecular and Cellular Endocrinology|May 4, 2002
Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor functionIlpo Huhtaniemi, Fu Ping Zhang, Jukka Kero, et al.
Cells|September 26, 2025
<i>Dicer1</i> Depletion Leads to DNA Damage Accumulation and Cell Death in a RET/PTC3 Papillary Thyroid Cancer Mouse Model, Thereby Inhibiting Tumor ProgressionMaria Rojo-Pardillo, Alice Augenlicht, Geneviève Dom, et al.
Oncogene|May 23, 2003
High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion geneMaarit Mikola, Jukka Kero, John H Nilson, et al.
Nature Medicine|February 4, 2003
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effectSorin Tunaru, Jukka Kero, Annette Schaub, et al.
Pediatric Research|June 6, 2022
Incidence of primary congenital hypothyroidism over 24 years in FinlandEmmi Danner, Laura Niuro, Hanna Huopio, et al.
Hormone Research in Paediatrics|December 8, 2022
Treatment of Congenital Hypothyroidism: Impact of Secular Changes in Levothyroxine Initial Dose on Early GrowthLaura Niuro, Emmi Danner, Liisa Viikari, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Genesis (New York, N.Y. : 2000)|January 8, 2014
A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activityHenriette Undeutsch, Christoffer Löf, Stefan Offermanns, et al.
Endocrinology|September 20, 2002
Transgenic mice harboring murine luteinizing hormone receptor promoter/beta-galactosidase fusion genes: different structural and hormonal requirements of expression in the testis, ovary, and adrenal glandTuula Hämäläinen, Jukka Kero, Matti Poutanen, et al.
The Journal of Clinical Investigation|February 15, 2011
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cellsMartina Lukasova, Camille Malaval, Andreas Gille, et al.
Molecular Pharmacology|August 16, 2005
Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G)Sorin Tunaru, Jens Lättig, Jukka Kero, et al.
Molecular and Cellular Endocrinology|May 4, 2002
Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor functionIlpo Huhtaniemi, Fu Ping Zhang, Jukka Kero, et al.
Cells|September 26, 2025
<i>Dicer1</i> Depletion Leads to DNA Damage Accumulation and Cell Death in a RET/PTC3 Papillary Thyroid Cancer Mouse Model, Thereby Inhibiting Tumor ProgressionMaria Rojo-Pardillo, Alice Augenlicht, Geneviève Dom, et al.
Oncogene|May 23, 2003
High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion geneMaarit Mikola, Jukka Kero, John H Nilson, et al.
Nature Medicine|February 4, 2003
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effectSorin Tunaru, Jukka Kero, Annette Schaub, et al.
Pediatric Research|June 6, 2022
Incidence of primary congenital hypothyroidism over 24 years in FinlandEmmi Danner, Laura Niuro, Hanna Huopio, et al.
Hormone Research in Paediatrics|December 8, 2022
Treatment of Congenital Hypothyroidism: Impact of Secular Changes in Levothyroxine Initial Dose on Early GrowthLaura Niuro, Emmi Danner, Liisa Viikari, et al.
Pageof 5